3. World Health Organization. WHO policy statement: molecular line-probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis. Geneva: World Health Organization; 2008.
8. Van Deun A, Aung KJ, Hossain A, de Rijk P, Gumusboga M, Rigouts L, et al. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. Int J Tuberc Lung Dis 2015;19:185-90.
9. Jo KW, Lee S, Kang MR, Sung H, Kim MN, Shim TS. Frequency and type of disputed rpoB mutations in
Mycobacterium tuberculosis isolates from South Korea. Tuberc Respir Dis 2017;80:270-6.
12. World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.
13. Sharma SK, Chaubey J, Singh BK, Sharma R, Mittal A, Sharma A. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India. Int J Tuberc Lung Dis 2017;21:1112-7.
14. Hofmann-Thiel S, Hoffmann H, Hillemann D, Rigouts L, Van Deun A, Kranzer K. How should discordance between molecular and growth-based assays for rifampicin resistance be investigated? Int J Tuberc Lung Dis 2017;21:721-6.
15. Paramasivan CN, Raizada N. Line probe assay: a look at non-interpretable results. Int J Tuberc Lung Dis 2016;20:146.
18. Andres S, Hillemann D, Rusch-Gerdes S, Richter E. Occurrence of rpoB mutations in isoniazid-resistant but rifampinsusceptible
Mycobacterium tuberculosis isolates from Germany. Antimicrob Agents Chemother 2014;58:590-2.
20. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant
Mycobacterium tuberculosis. J Clin Microbiol 2014;52:1846-52.
21. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, et al.
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol 2009;47:3501-6.
22. Mani C, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpoB gene of multidrug-resistant
Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001;39:2987-90.